Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
-
Follow Us
-
Search
- North America
- Latin America
September 18, 20264Tecpetrol Reopens US$450 Million Senior Notes Due 2033
September 18, 20264Sale of Minority Stake in Belo Horizonte International Airport to ASUR
September 18, 20264Rede D’Or Sells 49.99% Stake in Hospital Biocor to Bradesco Saúde for R$130 Million
- Europe
September 18, 20264Atomico Leads $100 Million Seed Investment in AI Infrastructure Startup Callosum
September 18, 20264Lauxera Capital Partners Completes $110 Million Investment in Bridge to Life
September 18, 20264Robert W. Johnson Acquires Stake in Aston Martin Aramco Formula One Team
- Africa
- Middle East
September 18, 20264$100 Million Trade Finance Facility Agreement Reached Between BADEA and The Gambia Government
September 11, 20264ACDIMA Sells 20% Stake in SPIMACO Through Block Trade and Accelerated Bookbuilding
August 11, 20264Zenity Secures $125 Million Series C Funding to Drive AI Agent Security Expansion
- Asia & Pacific
- Editorials
September 18, 20264Ellenoff Grossman & Schole Welcomes Evelyn Louie-Nam as new Chief Financial Officer
September 17, 20264Bignon Lebray appoints Pierre-Emmanuel Scherrer to its Executive Board
September 16, 20264Shardul Amarchand Mangaldas & Co. Elevated 7 Lawyers to Equity Partnership
- In & Out
September 18, 20264Barnes & Thornburg Expands Corporate and Labor and Employment Teams With Two Indianapolis Partners: Kristine Camron and Tom Stafford
September 18, 20264Hogan Lovells Cadwalader Strengthens Health Practice with Addition of Deborah Godes
September 18, 20264ArentFox Schiff Lands New Real Estate Litigation Leader Gabriel Levinson